Latest news
Loading news…
Cirius Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Kalamazoo, Michigan, United States Founded 2015 11-50 employees For Profit
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $100M to $500M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Active products
- 12
- IT spend
- $44K
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 35
- HQ
- Kalamazoo, Michigan, United States
- Region
- Great Lakes, Midwestern US
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.3
- Trend (30d)
- -0.5
- Trend (90d)
- 4.6
Key People at Cirius Therapeutics
Chief Financial Officer and Chief Business Officer
5
professional contacts at Cirius Therapeutics
Contact execs at Cirius Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cirius Therapeutics
Loading news…
FAQs about Cirius Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.